HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

oil red O

Also Known As:
solvent red 27; 1-((4-((dimethylphenyl)azo)dimethylphenyl)azo)-2- naphthalenol
Networked: 543 relevant articles (15 outcomes, 17 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Tang, Chao-Ke: 7 articles (01/2021 - 12/2017)
2. Yu, Xiao-Hua: 7 articles (01/2021 - 12/2017)
3. Ren, Daoyuan: 7 articles (07/2017 - 08/2014)
4. Yang, Xingbin: 7 articles (07/2017 - 08/2014)
5. Zhao, Yan: 6 articles (01/2019 - 08/2014)
6. Zhao, Zhen-Wang: 5 articles (01/2021 - 12/2017)
7. Zhang, Da-Wei: 5 articles (10/2020 - 01/2018)
8. Chen, Ling-Yan: 4 articles (01/2019 - 12/2017)
9. Gong, Duo: 4 articles (01/2019 - 12/2017)
10. Zheng, Xi-Long: 4 articles (01/2019 - 12/2017)

Related Diseases

1. Inflammation (Inflammations)
05/01/2019 - " the administration,the liver tissue and serum of mice were taken.HE and oil red O staining were using to observe the histopathological changes in liver;liver function to detect the serum and liver tissue as well as MDA and SOD levels;real-time quantitative PCR(RT-qPCR)was used to measure the mR-NA expression of NF-κB and TNF-α;Western blot and immunohistochemistry were used to measure the expression of NF-κB,TNF-αand COX-2 in liver tissue.RESULTS:: show that after AKT gene transfection,the model group had significant increase in the serum levels of AST,ALT,elevated the levels of MDA and decreased the levels of SOD in serum and liver tissue,aggravated histopathology degeneration and Liver inflammation,and significantly higher expression of NF-κB,TNF-α,IL-6,COX-2 and other inflammatory-related factors in liver tissue.EA administration group significant reductions in the serum levels of AST,ALT,and improved in hepatocyte fatty degeneration and liver inflammation,lower the levels of MDA and increased the levels of SOD in serum and liver tissue,and significant reductions in the expression of NF-κB,TNF-α,IL-6 and COX-2 in liver tissue.These"
08/20/2016 - "HE and oil red O staining demonstrated hepatic steatosis and inflammation in liver tissues. "
06/01/2009 - "Compared with the normal group, there were physiological changes associated with hepatic steatosis and inflammation in liver tissues in the untreated group as observed by oil red O staining and HE staining. "
05/20/2017 - "Blood and liver tissue samples were collected to measure biochemical parameters, hepatic steatosis and non-alcoholic fatty liver disease (NAFLD) activity score (inflammation) were evaluated by oil red O staining and HE staining, respectively. "
09/01/2023 - "Real-time qPCR, western blotting, and Oil Red O or Alcian blue staining were performed to evaluate inflammation, adipogenesis, and chondrogenesis. "
2. Atherosclerosis
3. Fibrosis (Cirrhosis)
4. Atherosclerotic Plaque (Atheroma)
5. Fatty Liver

Related Drugs and Biologics

1. Lipids
2. Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
3. Plasminogen Activator Inhibitor 1
4. Triglycerides (Triacylglycerol)
5. Cholesterol
6. Aspartate Aminotransferases (Aspartate Transaminase)
7. Alanine Transaminase (SGPT)
8. oxidized low density lipoprotein
9. Caspase 3 (Caspase-3)
10. Caspase 9

Related Therapies and Procedures

1. Aftercare (After-Treatment)
2. Fat-Restricted Diet (Diet, Fat Restricted)
3. Parathyroidectomy
4. Intravenous Administration
5. Immunomodulation